Related Experiment Video
Updated: Dec 23, 2025
Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012
Silica nanoparticle coated perfluorooctyl bromide for ultrasensitive MRI
Yaping Yuan1, Qianni Guo, Xiaoxiao Zhang
1Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy of Precision Measurement Science and Technology, Chinese Academy of Sciences-Wuhan National Laboratory for Optoelectronics, Wuhan 430071, P. R. China. xinzhou@wipm.ac.cn.
Abstract:
MRI with hyperpolarized 129Xe can achieve low-concentration detection. Herein, nanoparticle-coated perfluorooctyl bromide (PFOB) was developed as a 129Xe MRI contrast agent with a moderate exchange rate, sufficient stability and feasible surface modification. The αvβ3 integrin overexpressed by non-small-cell lung cancer A549 cells was successfully detected by 129Xe MRI with high specificity through adequate surface modifications.
Insights
Researchers developed nanoparticle-coated perfluorooctyl bromide (PFOB) as a novel contrast agent for 129-xenon MRI. This agent specifically detected alpha-v-beta-3 integrin overexpressed in non-small-cell lung cancer cells.
Area of Science:
- Medical Imaging
- Nanotechnology
- Oncology
Background:
- Hyperpolarized 129-xenon (Xe) magnetic resonance imaging (MRI) enables sensitive detection of low-concentration targets.
- Developing targeted contrast agents is crucial for enhancing specificity in molecular MRI.
Purpose of the Study:
- To develop and evaluate nanoparticle-coated perfluorooctyl bromide (PFOB) as a novel 129-Xe MRI contrast agent.
- To assess the agent's ability to detect alpha-v-beta-3 integrin, a biomarker overexpressed in non-small-cell lung cancer (NSCLC).
Main Methods:
- Synthesized nanoparticle-coated PFOB with controlled exchange rate, stability, and surface modification capabilities.
- Utilized 129-Xe MRI to image A549 cells (NSCLC model) with the developed contrast agent.
- Investigated the specificity of detection through targeted surface modifications.
Main Results:
- The nanoparticle-PFOB agent demonstrated a moderate exchange rate, good stability, and was amenable to surface functionalization.
- Successfully detected alpha-v-beta-3 integrin overexpressed on A549 NSCLC cells using 129-Xe MRI.
- Achieved high specificity in detecting the target biomarker through optimized surface modifications.
Conclusions:
- Nanoparticle-coated PFOB is a promising 129-Xe MRI contrast agent for targeted molecular imaging.
- This approach offers high specificity for detecting biomarkers like alpha-v-beta-3 integrin in non-small-cell lung cancer.
- Further development could advance early cancer detection and diagnosis using hyperpolarized 129-Xe MRI.
